< Back to previous page

Patent

Biomarkers for neurodegenerative and/or neuromuscular diseases

The present invention in general relates to the diagnosis of neurodegenerative and/or neuromuscular diseases such as Charcot- Marie-Tooth Disease, in particular type 2, and is based on the finding of 2 novel biomarkers (PFN2 and GAMT), shown to be downregulated in patients.
Patent Publication Number: EP3692169
Year filing: 2020
Year approval: 2021
Year publication: 2020
Status: Requested
Technology domains: Analysis of biological materials, Biotechnology
Validated for IOF-key: Yes
Attributed to: Associatie Universiteit & Hogescholen Antwerpen